NANOG and familial pancreatic carcinoma: Notably, treating pancreatic cancer cells with Stattic, a STAT3 inhibitor, substantially reversed the upregulation of mRNA expression of tumor stemness markers (NANOG, SOX2 and POU5F1) induced by IL20RB overexpression (Fig. 4C).